Lahuerta-Palacios J J, Bornstein R, Fernández-Debora F J, Gutiérrez-Rivas E, Ortiz M C, Larregla S, Calandre L, Montero-Castillo J
Department of Hematology, Hospital 1. de Octobre, Madrid, Spain.
Cancer. 1988 Mar 15;61(6):1207-12. doi: 10.1002/1097-0142(19880315)61:6<1207::aid-cncr2820610625>3.0.co;2-4.
Only two of 19 patients with spontaneously evolving essential thrombocythemia remained asymptomatic in a 421 patient-month observation. The rest of the patients showed hemorrhagic diathesis (four patients), nonspecific neurological semiology (two patients), and occlusive vascular illness in cerebral, myocardic, arterial, and often multiple locations (total, 12 patients). Peripheral neuropathy was found in five of 10 patients studied. In this series the incidence of cerebral ischemia in the uncontrolled condition was 180 times higher than the epidemiologic expectancy in a population not affected by the disorder. Of 35 ischemic attacks, 22 occurred when the platelet count was more than than 1000 X 10(9)/l, 13 when the count ranged from 650 to 990 X 10(9)/l, and none occurred at counts of less than 650 X 10(9)/l. In contrast, therapeutic control of the thrombocytosis caused all complications to disappear. These findings point out the danger of the natural course of the illness and justify active therapy. At the same time they call into question some of the most commonly used criteria in the diagnosis of essential thrombocythemia.
